Literature DB >> 18633482

Urinary proteomics: towards biomarker discovery, diagnostics and prognostics.

Visith Thongboonkerd1.   

Abstract

During recent years, the proteomics field has moved onward to clinical applications, particularly for biomarker discovery, diagnostics and prognostics of human diseases. The urine is one of the ideal clinical samples for such applications because it is readily available in almost all patients, and its collection is very simple and non-invasive. Urinary proteomics thus becomes one of the most interesting subdisciplines in the clinical proteomics area. This article highlights and updates recent progress in the urinary proteomics field for clinical applications.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18633482     DOI： 10.1039/b802534g

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN： 1742-2051


  18 in total

1.  One-step sample concentration, purification, and albumin depletion method for urinary proteomics.

Authors:  Ali R Vaezzadeh; Andrew C Briscoe; Hanno Steen; Richard S Lee
Journal:  J Proteome Res       Date:  2010-10-15       Impact factor: 4.466

2.  Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry.

Authors:  Joao A Paulo; Linda S Lee; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Pancreas       Date:  2012-03       Impact factor: 3.327

Review 3.  Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

Authors:  Massimo Papale; Salvatore Di Paolo; Grazia Vocino; Maria Teresa Rocchetti; Loreto Gesualdo
Journal:  J Nephrol       Date:  2014-02-25       Impact factor: 3.902

Review 4.  Mass spectrometry-based proteomics of endoscopically collected pancreatic fluid in chronic pancreatitis research.

Authors:  Joao A Paulo; Linda S Lee; Bechien Wu; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Proteomics Clin Appl       Date:  2011-03-01       Impact factor: 3.494

5.  Optimized sample preparation of endoscopic collected pancreatic fluid for SDS-PAGE analysis.

Authors:  Joao A Paulo; Linda S Lee; Bechien Wu; Kathryn Repas; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  Electrophoresis       Date:  2010-07       Impact factor: 3.535

6.  A comprehensive map of the human urinary proteome.

Authors:  Arivusudar Marimuthu; Robert N O'Meally; Raghothama Chaerkady; Yashwanth Subbannayya; Vishalakshi Nanjappa; Praveen Kumar; Dhanashree S Kelkar; Sneha M Pinto; Rakesh Sharma; Santosh Renuse; Renu Goel; Rita Christopher; Bernard Delanghe; Robert N Cole; H C Harsha; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2011-05-09       Impact factor: 4.466

7.  A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.

Authors:  Joao A Paulo; Vivek Kadiyala; Scott Brizard; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  JOP       Date:  2013-07-10

8.  Identification of novel translational urinary biomarkers for acetaminophen-induced acute liver injury using proteomic profiling in mice.

Authors:  Rachel P L van Swelm; Coby M M Laarakkers; Ellen C van der Kuur; Eva Morava-Kozicz; Ron A Wevers; Kevin D Augustijn; Daan J Touw; Maro H Sandel; Rosalinde Masereeuw; Frans G M Russel
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

9.  Adsorption of urinary proteins on the conventionally used urine collection tubes: possible effects on urinary proteome analysis and prevention of the adsorption by polymer coating.

Authors:  Iwao Kiyokawa; Kazuyuki Sogawa; Keiko Ise; Fumie Iida; Mamoru Satoh; Toshihide Miura; Ryo Kojima; Katsuhiro Katayama; Fumio Nomura
Journal:  Int J Proteomics       Date:  2011-09-12

10.  Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS.

Authors:  Longxiang Su; Lichao Cao; Ruo Zhou; Zhaoxu Jiang; Kun Xiao; Weijing Kong; Huijuan Wang; Jie Deng; Bo Wen; Fengji Tan; Yong Zhang; Lixin Xie
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.